文献速递心脏核医学

碲锌镉单光子发射计算机断层扫描心肌灌注显像对疑似或已知冠状动脉粥样硬化性心脏病患者不良心血管事件的预后价值:系统评价与荟萃分析

Prognostic value of myocardial perfusion imaging by cadmium zinc telluride single-photon emission computed tomography in patients with suspected or known coronary artery disease: a systematic review and meta-analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-07-22

该系统评价与荟萃分析纳入12项研究共36415例疑似或已知冠状动脉粥样硬化性心脏病患者,评估碲锌镉单光子发射计算机断层扫描负荷心肌灌注显像对不良心血管事件的预后价值。汇总风险比为2.17(95%CI 1.78-2.65),校正后汇总风险比为1.69(95%CI 1.44-1.98),不良心肌灌注患者事件发生率比值为2.38(95%CI 1.39-4.06)。作者认为该显像是有价值的无创预后指标。

要点

  • 碲锌镉单光子发射计算机断层扫描负荷心肌灌注显像异常与不良心血管事件风险升高相关,汇总风险比2.17(95%CI 1.78-2.65)。
  • 校正后汇总风险比为1.69(95%CI 1.44-1.98),异质性44.9%(P=0.123)。
  • 不良与正常心肌灌注患者的事件发生率比值为2.38(95%CI 1.39-4.06),异质性84.6%(P<0.001)。

核心结论

  • 碲锌镉单光子发射计算机断层扫描负荷心肌灌注显像是疑似或已知冠状动脉粥样硬化性心脏病患者不良心血管事件的有价值无创预后指标。

研究设计与样本

  • 系统评价与荟萃分析,检索截至2022年11月发表的文献,最终纳入12项研究共36415例疑似或已知冠状动脉粥样硬化性心脏病患者。

主要发现

  • 不良心血管事件发生的汇总风险比为2.17(95%CI 1.78-2.65),异质性66.1%(P=0.001)。
  • 5项研究报告校正后风险比,汇总风险比为1.69(95%CI 1.44-1.98),异质性44.9%(P=0.123)。
  • 7项研究报告未校正风险比,汇总风险比为2.72(95%CI 2.00-3.70)。
  • 9项研究可分别计算异常与正常心肌灌注患者的不良事件发生率,汇总发生率比值为2.38(95%CI 1.39-4.06),异质性84.6%(P<0.001)。
  • 漏斗图未见不对称证据(P=0.517);荟萃回归分析发现不良事件风险比与心绞痛症状及冠状动脉粥样硬化性心脏病家族史相关。

关键数值与推荐

  • 汇总风险比2.17(95%CI 1.78-2.65)对应不良心血管事件发生。
  • 校正后汇总风险比1.69(95%CI 1.44-1.98)对应不良心血管事件发生。
  • 未校正汇总风险比2.72(95%CI 2.00-3.70)对应不良心血管事件发生。
  • 汇总发生率比值2.38(95%CI 1.39-4.06)对应异常与正常心肌灌注患者的不良事件发生率比较。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 汇总风险比异质性66.1%(P=0.001)。
  • 汇总发生率比值异质性84.6%(P<0.001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aim of this study was to define the prognostic value of stress myocardial perfusion imaging by cadmium zinc telluride (CZT) single-photon emission computed tomography (SPECT) for prediction of adverse cardiovascular events in patients with known or suspected coronary artery disease (CAD). METHODS AND RESULTS: Studies published until November 2022 were identified by database search. We included studies using stress myocardial perfusion imaging by CZT-SPECT to evaluate subjects with known or suspected CAD and providing primary data of adverse cardiovascular events. Total of 12 studies were finally included recruiting 36,415 patients. Pooled hazard ratio (HR) for the occurrence of adverse events was 2.17 (95% confidence interval, CI, 1.78-2.65) and heterogeneity was 66.1% (P = 0.001). Five studies reported data on adjusted HR for the occurrence of adverse events. Pooled HR was 1.69 (95% CI, 1.44-1.98) and heterogeneity was 44.9% (P = 0.123). Seven studies reported data on unadjusted HR for the occurrence of adverse events. Pooled HR was 2.72 (95% CI, 2.00-3.70). Nine studies reported data useful to calculate separately the incidence rate of adverse events in patients with abnormal and normal myocardial perfusion. Pooled incidence rate ratio was 2.38 (95% CI, 1.39-4.06) and heterogeneity was 84.6% (P < 0.001). The funnel plot showed no evidence of asymmetry (P = 0.517). At meta-regression analysis, we found an association between HR for adverse events and presence of angina symptoms and family history of CAD. CONCLUSIONS: Stress myocardial perfusion imaging by CZT-SPECT is a valuable noninvasive prognostic indicator for adverse cardiovascular events in patients with known or suspected CAD.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Assante R, Zampella E, Cantoni V, et al. Prognostic value of myocardial perfusion imaging by cadmium zinc telluride single-photon emission computed tomography in patients with suspected or known coronary artery disease: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2023. PMID: 37480369. doi:10.1007/s00259-023-06344-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。